Tania Jain, Associate Professor of Oncology at Johns Hopkins, shared a post on X about a paper she co-authored with colleagues published in JCO Oncology Practice:
“Every time another malignancy was noted in MPN patients, this question came up — more yet to be understood but starts with an overall assessment of the burden and it’s high!”
Title: Risk and Outcomes of Second Malignancies in Patients With Philadelphia Chromosome–Negative Myeloproliferative Neoplasm: A SEER Database Analysis
Authors: Rahul Mishra, Arindam Bagga, Noha Sharafeldin, Ruchi Desai, Pankit Vachhani, Tania Jain
You can read the full article in JCO Oncology Practice.
